Holen Sie sich die Stockscreener-App
4.55
2.94%
0.13
Handel nachbörslich:
4.56
0.010
+0.22%
Maravai Lifesciences Holdings Inc Aktie (MRVI) Neueste Nachrichten
What Do Analysts Think About Maravai LifeSciences Holdings Inc’s (NASDAQ:MRVI) Future? - Stocks Register
Royce & Associates LP Raises Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
Maravai LifeSciences (NASDAQ:MRVI) Stock Price Down 7.5%Here's What Happened - MarketBeat
(MRVI) Trading Report - Stock Traders Daily
Maravai Lifesciences stock hits 52-week low at $4.68 - Investing.com
Steven Cohen's Strategic Acquisition in Maravai LifeSciences - GuruFocus.com
Maravai LifeSciences shares initiated with Peerperform on positive aspects - Investing.com India
Maravai lifesci director John DeFord acquires $100,625 in stock - Investing.com
Insider Buying: Director John Deford Acquires Shares of Maravai LifeSciences Holdings Inc (MRVI) - GuruFocus.com
Maravai LifeSciences shares initiated with Peerperform on positive aspects By Investing.com - Investing.com Canada
Maravai LifeSciences (NASDAQ:MRVI) Now Covered by Wolfe Research - MarketBeat
Maravai LifeSciences Target of Unusually Large Options Trading (NASDAQ:MRVI) - MarketBeat
Wolfe Research Initiates Coverage of Maravai LifeSciences Holdings (MRVI) with Peer Perform Recommendation - MSN
12 West Capital Management LP's Strategic Acquisition in Maravai LifeSciences Holdings Inc - GuruFocus.com
Maravai LifeSciences (NASDAQ:MRVI) Shares Gap Up Following Insider Buying Activity - MarketBeat
Maravai LifeSciences Announces November 2024 Investor Conference Schedule - GlobeNewswire
Earnings call: Maravai LifeSciences reports mixed Q3 results, eyes growth - Investing.com India
Maravai LifeSciences (NASDAQ:MRVI) Price Target Cut to $13.00 by Analysts at Royal Bank of Canada - Defense World
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q3 2024 Earnings Call Transcript - Insider Monkey
Slammed 37% Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Screens Well Here But There Might Be A Catch - Simply Wall St
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance
Maravai LifeSciences (NASDAQ:MRVI) Shares Gap Down on Analyst Downgrade - Defense World
Maravai Lifesciences price target lowered to $9 from $10 at Baird - Yahoo Finance
Health Care Up on Another Round of Mixed Earnings -- Health Care Roundup - Marketscreener.com
Royal Bank of Canada Has Lowered Expectations for Maravai LifeSciences (NASDAQ:MRVI) Stock Price - MarketBeat
Maravai LifeSciences stock plunges 39% amid lowered revenue forecast - MSN
Maravai LifeSciences stock plunges 39% amid lowered revenue forecast (NASDAQ:MRVI) - Seeking Alpha
U.S. Stock market: Evolent Health(-43.35%), Maravai LifeSciences(-38.65%), and Chanson International(-38.04%) in midday trading - Business Upturn
Maravai LifeSciences (NASDAQ:MRVI) Shares Gap Down Following Analyst Downgrade - MarketBeat
U.S. Stock market: Evolent Health (-41.07%), Maravai LifeSciences(-34.44%), Revance Therapeutics(-32.01%) as top losers during early trading - Business Upturn
Maravai LifeSciences (NASDAQ:MRVI) Given New $9.00 Price Target at Robert W. Baird - MarketBeat
Maravai LifeSciences' (MRVI) Market Perform Rating Reaffirmed at William Blair - MarketBeat
Decoding 5 Analyst Evaluations For Maravai LifeSciences - Benzinga
Maravai LifeSciences (MRVI) Q3 2024 Earnings Call Transcript - AOL
Maravai LifeSciences Holdings Inc (MRVI) Q3 2024 Earnings Call Highlights: Navigating ... By GuruFocus - Investing.com Canada
Maravai LifeSciences Holdings Inc (MRVI) Q3 2024 Earnings Call Highlights: Navigating ... - Yahoo Finance
Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research - BioSpace
Maravai LifeSciences Reports Q3 Earnings and Strategic Acquisition - TipRanks
Maravai LifeSciences stock plunges on weak Q3 results, lowered guidance By Investing.com - Investing.com South Africa
Maravai LifeSciences stock plunges on weak Q3 results, lowered guidance - Investing.com
Maravai Lifesciences earnings missed by $0.01, revenue fell short of estimates - Investing.com UK
Maravai to acquire Officinae Bio's DNA, RNA business By Investing.com - Investing.com South Africa
Maravai LifeSciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Maravai LifeSciences Reports Third Quarter 2024 Financial Results - GlobeNewswire
Maravai LifeSciences Holdings Inc (MRVI) Recovers 77.65% From Low: Are We There Yet? - Stocks Register
Maravai LifeSciences Holdings (STU:MAR) Growth Rank : 8 (As of Nov. 05, 2024) - GuruFocus.com
(MRVI) Investment Analysis and Advice - Stock Traders Daily
Maravai LifeSciences Holdings (STU:MAR) GF Value Rank : 9 (As of Nov. 05, 2024) - GuruFocus.com
MRVI Stock Surges Amid Biotechnology Sector Fluctuations - GuruFocus.com
Cannon Global Investment Management LLC Makes New $590,000 Investment in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
Roubaix Capital LLC Trims Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
Maravai LifeSciences Sees Unusually Large Options Volume (NASDAQ:MRVI) - MarketBeat
Maravai LifeSciences (MRVI) to Release Earnings on Thursday - MarketBeat
Maravai LifeSciences (NASDAQ:MRVI) Trading Up 7%Still a Buy? - MarketBeat
Millennium Management LLC Adjusts Stake in Maravai LifeSciences Holdings Inc - GuruFocus.com
Where Do Analysts See Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) Heading? - Stocks Register
Blue Trust Inc. Acquires 11,215 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives $10.67 Average PT from Brokerages - MarketBeat
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):